docetaxel anhydrous has been researched along with Autoimmune Thrombocytopenia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Onari, Y; Otani, T; Yamane, M | 1 |
| Chumsri, S; Zimrin, A | 1 |
2 other study(ies) available for docetaxel anhydrous and Autoimmune Thrombocytopenia
| Article | Year |
|---|---|
[A Case of Lung Cancer Associated with Drug-Induced Immune Thrombocytopenia].
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged, 80 and over; Antineoplastic Agents; Docetaxel; Humans; Lung Neoplasms; Male; Platelet Count; Purpura, Thrombocytopenic, Idiopathic; Taxoids | 2017 |
Profound thrombocytopenia in patient with ITP treated with chemotherapy for breast cancer and subsequent remission after romiplostim.
Topics: Antineoplastic Combined Chemotherapy Protocols; Benzoates; Bone Marrow; Breast Neoplasms; Cyclophosphamide; Docetaxel; Drug Resistance; Female; Humans; Hydrazines; Mastectomy, Segmental; Middle Aged; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Receptors, Estrogen; Receptors, Fc; Recombinant Fusion Proteins; Remission Induction; Splenectomy; Taxoids; Thrombocytopenia; Thrombopoietin | 2013 |